The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
基本信息
- 批准号:8508271
- 负责人:
- 金额:$ 45.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adenine Nucleotide TranslocaseAdenine NucleotidesAgonistArginineAttenuatedBindingBiologicalCell DeathCell NucleusCell divisionCell physiologyCellsCellular biologyCentrosomeChemicalsChronic DiseaseComplexCouplingCultured CellsCytoskeletonCytosolDataDiabetes MellitusEnergy MetabolismEukaryotaEukaryotic CellFamilyGTPase-Activating ProteinsGenerationsGenetic TranscriptionGolgi ApparatusGrowthGuanosine Triphosphate PhosphohydrolasesHealthHormonesIn VitroInner mitochondrial membraneLaboratoriesLeadLinkLocationMaintenanceMalignant NeoplasmsMediatingMembrane Protein TrafficMicrotubulesMitochondriaMitochondrial ProteinsModelingMolecularMolecular ChaperonesMolecular ModelsMorphologyNeurodegenerative DisordersOrthologous GeneOxygen ConsumptionPaclitaxelPhenotypePlayProductionProkaryotic CellsPropertyProteinsRecruitment ActivityRegulationRoleSLC25A4 geneSignal PathwaySignal TransductionSiteSite-Directed MutagenesisSpecificityStressTertiary Protein StructureTestingTubulincell growth regulationcell motilitychemotherapeutic agentcofactorcytokineenergy balancemembermitochondrion intermembrane spacemolecular modelingnovelprotein complexpublic health relevanceresponsetumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The Arf family of regulatory GTPases, within the Ras superfamily, emerged in prokaryotes and members of the Arf family, Arfs and Arl2, have been implicated as critical components in the endosymbiotic origins of eukaryotes. As such they are predicted to have essential roles in the regulation of cell biology in all eukaryotes. We and others have previously provided evidence for a role for Arl2 in microtubule growth in cells but more recently we have discovered an obligate role for Arl2 in maintenance of energy (ATP) levels that is predicted to be its fundamental role in eukaryotes. In this application I propose to develop molecular models of Arl2 regulation of ATP levels, as well as for the newly identified Arl2 GAPs/effectors in the ELMO (Engulfment and cell motility) family, that regulate mitochondria and Golgi morphology. This application has three specific aims. (1) Determine the role of Arl2 in maintenance of ATP levels. (2) Characterize the GAP domain of ELMOD2 and its actions in mitochondria including specifically its role in mitochondrial morphology. (3) Determine the specificity and functions of ELMOD1. I hypothesize that ELMOD1 acts in cells as an ArfGAP that can attenuate Arf signaling at the Golgi and impact membrane traffic also at the TGN, where it has effector properties. Together these aims will provide detailed molecular models of an ancient means of regulating energy metabolism in perhaps all eukaryotic cells, with ties to cell division, the cytoskeleton, and the regulation of gene transcription in the nucleus. These studies have the potential to fundamentally alter our understanding of essential cellular processes with ties to energy metabolism, cancer, sensitivity to cancer chemotherapeutics, and gene transcription.
PUBLIC HEALTH RELEVANCE: Maintenance of proper energy balance is essential to the health and function of all cells and is the primary responsibility of mitochondria, the site of chemical energy (ATP) generation and oxygen consumption. Dramatic changes in energy utilization are known to accompany chronic diseases including cancer, neurodegenerative diseases, and diabetes. We have discovered novel signaling pathways that are involved in regulating cellular ATP levels and the morphology of the mitochondria and Golgi compartments that are tied to the ancient and highly conserved regulatory GTPase Arl2. In this application I propose three specific aims that will elucidate molecular mechanisms of Arl2 and Arl2 GTPase activating protein actions as regulators of ATP production, mitochondria morphology, and Golgi integrity with predicted links to cell division and the cell cytoskeleton.
描述(由申请人提供):RAS超家族内的ARF家族在原核组织和ARF家族,ARFS和ARL2的成员中出现在真核生物的内共生型起源中。因此,预计它们在所有真核生物的细胞生物学调节中都具有重要作用。我们和其他人先前已经提供了ARL2在细胞中微管生长中的作用的证据,但最近我们发现了ARL2在维持能量(ATP)水平(ATP)水平中的专有作用,这预计将其在真核生物中的基本作用。在此应用中,我建议开发ARL2调节ATP水平的分子模型,以及Elmo(吞噬和细胞运动)家族中新鉴定的ARL2差距/效应子,这些差异/效应子(吞噬和细胞运动)都调节了线粒体和高尔基体的形态。该应用程序具有三个具体目标。 (1)确定ARL2在维持ATP水平中的作用。 (2)表征ELMOD2的间隙结构及其在线粒体中的作用,包括其在线粒体形态中的作用。 (3)确定ELMOD1的特异性和功能。我假设ELMOD1在细胞中充当ARFGAP,可以减弱高尔基体的ARF信号传导,并在TGN上也具有效应特性的TGN膜流量。这些目标将共同提供详细的分子模型,以调节所有真核细胞中的能量代谢,并与细胞分裂,细胞骨架和细胞核中基因转录的调节。这些研究有可能从根本上改变我们对基本细胞过程的理解,并与能量代谢,癌症,对癌症化学治疗疗法的敏感性和基因转录有联系。
公共卫生相关性:维持适当的能量平衡对于所有细胞的健康和功能至关重要,是线粒体(ATP)产生和氧气消耗的线粒体的主要责任。已知能量利用的急剧变化伴随着包括癌症,神经退行性疾病和糖尿病在内的慢性疾病。我们发现了与调节细胞ATP水平的新型信号通路以及线粒体和高尔基体隔室的形态,这些途径与古代和高度保守的调节GTPase ARL2相关。在此应用中,我提出了三个特定目标,将阐明ARL2和ARL2 GTPase的分子机制激活蛋白质作用,作为ATP产生的调节剂,线粒体形态和高尔基体完整性,并具有与细胞分裂和细胞细胞骨架的预测联系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard A Kahn其他文献
Richard A Kahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard A Kahn', 18)}}的其他基金
The Regulation and Cellular Activities of the ARL2 GTPase
ARL2 GTPase 的调节和细胞活性
- 批准号:
8964313 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
8330939 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The Regulation and Cellular Activities of the ARL2 GTPase
ARL2 GTPase 的调节和细胞活性
- 批准号:
9268023 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
7987019 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
8460228 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
相似国自然基金
烟酰胺腺嘌呤二核苷酸从头合成新途径的发现与解析
- 批准号:32370058
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
腺嘌呤核苷酸转位酶2的下调抑制线粒体ATP合成介导纳米塑料致大脑神经元铁死亡的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
腺嘌呤核苷酸转位酶2的下调抑制线粒体ATP合成介导纳米塑料致大脑神经元铁死亡的机制研究
- 批准号:82273656
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
2型糖尿病异常的腺嘌呤核苷酸信号调节肾脏糖异生机制的研究
- 批准号:32100946
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
2型糖尿病异常的腺嘌呤核苷酸信号调节肾脏糖异生机制的研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
New Generation of Mitochondrial Uncouplers for the Treatment of Metabolic DIsorders
用于治疗代谢紊乱的新一代线粒体解偶联剂
- 批准号:
10383829 - 财政年份:2021
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
8330939 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
7987019 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
8460228 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别:
The regulation and cellular activities of the Arl2 GTPase
Arl2 GTPase 的调节和细胞活性
- 批准号:
8136656 - 财政年份:2010
- 资助金额:
$ 45.6万 - 项目类别: